Mangalam Drugs & Organics Ltd

MANGALAM

Company Profile

  • Business description

    Mangalam Drugs & Organics Ltd commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is engaged in the manufacture and sale of APIs for various therapeutic segments, including anti-malaria, anti-retroviral, and anti-hypertensive. It is approved by the Bill Clinton Foundation. The company is actively producing Pyronaridine Tetraphosphate, a new API used in antimalarial treatments. The company has received prequalification from the World Health Organization (WHO) for both micronized and non-micronized forms of Pyronaridine Phosphate.

  • Contact

    P. D'Mello Road
    Rupam Building, 3rd Floor, No. 239
    Near General Post Office
    MumbaiMH400001
    IND

    T: +91 2222616200

    https://www.mangalamdrugs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    480

Stocks News & Analysis

stocks

Are small caps finally back?

Does renewed investor interest point to a structural shift in the underperforming factor?
stocks

Chart of the Week: Modest earnings growth at odds with overvalued bank shares

The latest update from our Industry Pulse report.
stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,329.1050.900.55%
CAC 408,256.3549.480.60%
DAX 4024,139.8411.29-0.05%
Dow JONES (US)46,589.730.68-0.00%
FTSE 1009,591.4276.420.80%
HKSE25,967.98186.210.72%
NASDAQ22,735.704.69-0.02%
Nikkei 22548,641.61666.18-1.35%
NZX 50 Index13,377.1070.660.53%
S&P 5006,704.415.010.07%
S&P/ASX 2009,032.8046.600.52%
SSE Composite Index3,922.418.650.22%

Market Movers